Patient Preferences

hylenex recombinant-facilitated Sub-Q rehydration was well accepted by responding parents and guardians

The majority of responding parents/guardians prefer hylenex recombinant¹

In the INFUSE PEDS 1 Study:

Satisfaction
9 out of 10 (43/48) responding parents/guardians were satisfied or very satisfied with hylenex recombinant-facilitated Sub-Q rehydration.¹

Experience
9 out of 10 (31/34) responding parents and guardians whose children had previously received IV fluids said their experience with hylenex recombinant-facilitated Sub-Q rehydration was the same or better.¹

^1. Allen C, Etzwiler L, Miller M, Maher G, Mace S. Recombinant Human Hyaluronidase-Enabled Subcutaneous Pediatric Rehydration. PEDIATRICS Volume 124, Number 5, November 2009.

Please refer to the INFUSE PEDS 1 Study design details. Please refer to Indication and Important Risk Information. Please see the accompanying full Prescribing Information.

Important Risk Information for Patients

Indication

HYLENEX recombinant is used for subcutaneous fluid administration, the infusion of fluids under the skin

Important Risk Information

You should not take HYLENEX if you’ve ever had an allergic reaction to products containing hyaluronidase.
Tell your doctor about all the medications you take, including over the counter medications.
HYLENEX should not be used to reduce the swelling of bites or stings.
HYLENEX should not be used near any area that is infected or inflamed.
The most frequently reported adverse reactions have been mild, local injection site reactions, such as redness, swelling, itching or pain.
Rarely, patients have reported serious allergic reactions. Seek immediate medical attention if you have an allergic reaction or have trouble swallowing or breathing.
These are not all of the side effects for HYLENEX. Please contact your doctor for more information.